CHEK2 and posterior cortical atrophy: Of note, the c.1100delC mutation was the most commonly observed CHEK2 mutation and was found to have a significantly higher frequency in lethal cases compared than in the low-risk PCa patients, supporting the importance of this mutation for lethal PCa [14].